References

  1. Yuen MF, Hou JL, Chutaputti A; Asia Pacific Working Party on Prevention of Hepatocellular Carcinoma. Hepatocellular carcinoma in the Asia pacific region. J Gastroenterol Hepatol. 2009 Mar; 24(3):346-53. PubMed | Google Scholar

  2. Zidan A, Scheuerlein H, Schüle S, Settmacher U, Rauchfuss F. Epidemiological pattern of hepatitis B and hepatitis C as etiological agents for hepatocellular carcinoma in iran and worldwide. Hepat Mon. 2012 Oct;12(10 HCC):e6894. PubMed | Google Scholar

  3. Lodato F, Mazzella G, Festi D, Azzaroli F, Colecchia A, Roda E. Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations. World J Gastroenterol. 2006 Dec 7; 12(45):7239-49. PubMed | Google Scholar

  4. Jepsen P, Vilstrup H, Tarone RE, Friis S, Sørensen HT. Incidence rates of hepatocellular carcinoma in the US and Denmark: recent trends. Int J Cancer. 2007 Oct 1; 121(7):1624-6. PubMed | Google Scholar

  5. El-Serag HB.Epidemiology of hepatocellular carcinoma in USA. Hepatol Res. 2007 Sep; 37 Suppl 2:S88-94. PubMed | Google Scholar

  6. David Yiu-Kuen But, Ching-Lung Lai, and Man-Fung Yuen. Natural history of hepatitis-related hepatocellular carcinoma World. J Gastroenterol. 2008 March 21; 14(11): 1652–1656. PubMed | Google Scholar

  7. Stroffolini T. Etiological factor of hepatocellular carcinoma in Italy. Minerva Gastroenterol Dietol. 2005 Mar; 51(1):1-5. PubMed | Google Scholar

  8. Wild CP, Hall AJ. Primary prevention of hepatocellular carcinoma in developing countries. Mutat Res. 2000 Apr; 462(2-3):381-93. PubMed | Google Scholar

  9. Lok AS. Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma? J Gastroenterol Hepatol. 2011 Feb; 26(2):221-7. Google Scholar

  10. Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements. J Gastroenterol Hepatol. 2010 Apr; 25(4):657-63. PubMed | Google Scholar

  11. Shi J, Zhu L, Liu S, Xie WF.A meta-analysis of case-control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China. Br J Cancer. 2005 Feb 14; 92(3):607-12. PubMed | Google Scholar

  12. Michielsen PP, Francque SM, van Dongen JL. Viral hepatitis and hepatocellular carcinoma. World J Surg Oncol. 2005 May 20; 3:27. PubMed | Google Scholar

  13. Vaiphei K, Pal NS, Arora SK. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study. Indian J Pathol Microbiol. 2006 Jul; 49(3):357-61. PubMed | Google Scholar

  14. Michielsen P, Ho E. Viral hepatitis B and hepatocellular carcinoma. Acta Gastroenterol Belg. 2011 Mar; 74(1):4-8. PubMed | Google Scholar

  15. Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004 Nov; 127(5 Suppl 1):S35-50. PubMed | Google Scholar

  16. Monto A, Wright TL. The epidemiology and prevention of hepatocellular carcinoma. Semin Oncol. 2001 Oct; 28(5):441-9. PubMed | Google Scholar

  17. Di Bisceglie AM, Simpson LH, Lotze MT, Hoofnagle JH. Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection. J Clin Gastroenterol. 1994 Oct; 19(3):222-6. PubMed | Google Scholar

  18. Kumar M, Kumar R, Hissar SS, Saraswat MK, Sharma BC, Sakhuja P, Sarin SK. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India. J Gastroenterol Hepatol. 2007 Jul; 22(7):1104-11. PubMed | Google Scholar